SIDP has developed COVID-19 Monoclonal Antibody (mAb) Toolkits for Treatment, Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) informed by the experiences of pharmacists who have implemented mAb infusions for COVID-19 patients at their institutions.
SIDP member, Nick Piccicacco, PharmD (right) discussing mAb therapeutics with a physician colleague
COVID-19 mAb Survey Results
Developing an Infusion Process
Products and Compounding Resources
Example Orders and Order Sets
Provider and Patient Resources
Clinical Data & Useful Links
Register to Access Toolkit Resources
SIDP will not share any contact information provided with any third party and
will only contact registered resource users with information pertaining to educational resources
Once you have signed up as a Registered Resource User, access the toolkit resources using the link below!
Note, SIDP members can also access the toolkit at the link below.
Please keep in mind that information, data, and availability of mAbs in COVID-19 is constantly evolving. Use of SIDP guidelines and/or toolkits are intended as recommendations. Use does not supersede clinical judgement based on the assessment of an individual patient by an individual practitioner. The recommendations reflect the best available evidence at the time of publication and are not the sole resource for patient care management and/or an exclusive source of action.
SIDP COVID-19 Monoclonal Antibody Toolkit Taskforce Members
Special thanks to the following SIDP members for volunteering their time and efforts to the development of this toolkit:
SIDP member, Kristen Zeitler, PharmD delivering COVID-19 mAb doses
This toolkit was sponsored by unrestricted medical grants from Regeneron Pharmaceuticals, Inc. and AstraZeneca
Release Date 07/09/2021, Updated 03/09/2022